Matches in Wikidata for { <http://www.wikidata.org/entity/Q63318850> ?p ?o ?g. }
Showing items 1 to 59 of
59
with 100 items per page.
- Q63318850 description "clinical trial" @default.
- Q63318850 description "ensayu clínicu" @default.
- Q63318850 description "klinisch onderzoek" @default.
- Q63318850 description "клінічне випробування" @default.
- Q63318850 description "临床试验" @default.
- Q63318850 name "A Study to Evaluate the Safety and Efficacy of ASP015K in Moderate to Severe Rheumatoid Arthritis Subjects Who Have Had an Inadequate Response to Methotrexate" @default.
- Q63318850 type Item @default.
- Q63318850 label "A Study to Evaluate the Safety and Efficacy of ASP015K in Moderate to Severe Rheumatoid Arthritis Subjects Who Have Had an Inadequate Response to Methotrexate" @default.
- Q63318850 prefLabel "A Study to Evaluate the Safety and Efficacy of ASP015K in Moderate to Severe Rheumatoid Arthritis Subjects Who Have Had an Inadequate Response to Methotrexate" @default.
- Q63318850 P1050 Q63318850-5BC76286-69D8-49F5-9EE1-A347A1B9CBEA @default.
- Q63318850 P1132 Q63318850-53907C93-65F2-4312-ABD0-2E1EF0DEDBAD @default.
- Q63318850 P1476 Q63318850-9CB18DEA-A05E-4B8D-98BC-761D43D6F71A @default.
- Q63318850 P17 Q63318850-178F7AD8-B620-4CEA-ADDD-0ABA1BD79E61 @default.
- Q63318850 P17 Q63318850-48A90239-0217-4EC0-9849-403B3CB4DB45 @default.
- Q63318850 P17 Q63318850-650BCF62-FA88-413E-8564-80FB2CB8D5F5 @default.
- Q63318850 P17 Q63318850-8ED7DF6B-38D8-4401-BEAF-283DBACAA0E5 @default.
- Q63318850 P17 Q63318850-96203322-F165-4BA9-9460-DCEAE2978A0D @default.
- Q63318850 P17 Q63318850-977B54F5-5658-4082-BCE2-12A54A01E4D3 @default.
- Q63318850 P17 Q63318850-CC3B2E60-CEDE-4F1C-A445-4C5B5A80ACC4 @default.
- Q63318850 P17 Q63318850-E7DAF26D-4B1E-4693-A3BA-3730F99CED10 @default.
- Q63318850 P2899 Q63318850-2C937BD4-F84D-4276-A6BB-75863BDEFB1E @default.
- Q63318850 P3098 Q63318850-9424A574-5EC1-4778-9C43-12E6E7F0D57F @default.
- Q63318850 P31 Q63318850-2DA41F21-1928-48C8-9BAC-09A4EC1707E5 @default.
- Q63318850 P4844 Q63318850-78314C67-47AE-490D-842F-EF091BCEDF5D @default.
- Q63318850 P4844 Q63318850-80EC48AA-4DD1-496F-9617-D32B94ED5043 @default.
- Q63318850 P4844 Q63318850-ECE5A77C-65F7-4A75-8DB9-E832205BA4D1 @default.
- Q63318850 P580 Q63318850-3F32C8DE-0240-4B53-BBAA-02D0A245C247 @default.
- Q63318850 P582 Q63318850-3D7D917D-48BA-4DF2-BA35-F9A8A3E47D19 @default.
- Q63318850 P6099 Q63318850-45B83C96-330C-4C37-B465-63AA67FF55BF @default.
- Q63318850 P6153 Q63318850-6235DC31-B163-4C07-9658-E7FFFEC84296 @default.
- Q63318850 P6153 Q63318850-E13D4871-98D6-4833-843C-592864CBC0F2 @default.
- Q63318850 P6153 Q63318850-F470B88D-79E5-4B40-8C9C-666CB0F953EC @default.
- Q63318850 P8005 Q63318850-035EC68B-32F5-43EA-9242-5FD08AA8CFC5 @default.
- Q63318850 P8363 Q63318850-599E7FF0-44BC-4256-9A39-EA8BEEA92A5B @default.
- Q63318850 P1050 Q170990 @default.
- Q63318850 P1132 "+379" @default.
- Q63318850 P1476 "A Phase 2b, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled, Dose-Finding, Multi-Center Study to Evaluate the Safety and Efficacy of ASP015K in Moderate to Severe Rheumatoid Arthritis Subjects Who Have Had an Inadequate Response to Methotrexate" @default.
- Q63318850 P17 Q213 @default.
- Q63318850 P17 Q219 @default.
- Q63318850 P17 Q28 @default.
- Q63318850 P17 Q30 @default.
- Q63318850 P17 Q31 @default.
- Q63318850 P17 Q36 @default.
- Q63318850 P17 Q739 @default.
- Q63318850 P17 Q96 @default.
- Q63318850 P2899 "+18" @default.
- Q63318850 P3098 "NCT01554696" @default.
- Q63318850 P31 Q30612 @default.
- Q63318850 P4844 Q192423 @default.
- Q63318850 P4844 Q27088288 @default.
- Q63318850 P4844 Q422232 @default.
- Q63318850 P580 "2012-06-01T00:00:00Z" @default.
- Q63318850 P582 "2014-02-01T00:00:00Z" @default.
- Q63318850 P6099 Q42824440 @default.
- Q63318850 P6153 Q30269584 @default.
- Q63318850 P6153 Q30270033 @default.
- Q63318850 P6153 Q574606 @default.
- Q63318850 P8005 Q76651189 @default.
- Q63318850 P8363 Q78089383 @default.